Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 27;8(3):rkae086.
doi: 10.1093/rap/rkae086. eCollection 2024.

Prevalence, incidence, and mortality of Raynaud's phenomenon, Sjögren's syndrome and scleroderma: an umbrella review of systematic reviews

Anthony Chen  1 , Stephanie J Lax  1 , Matthew J Grainge  1 , Peter C Lanyon  1   2 , Fiona A Pearce  1   2
Affiliations
Review

Prevalence, incidence, and mortality of Raynaud's phenomenon, Sjögren's syndrome and scleroderma: an umbrella review of systematic reviews

Anthony Chen et al. Rheumatol Adv Pract. .

Abstract

Objectives: To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud's, Sjögren's and Scleroderma, and to identify any research gaps.

Methods: An umbrella review of English language systematic reviews was undertaken using PubMed and Embase (OVID) covering the period 2000-2023 (PROSPERO CRD42023434865). The estimate and its corresponding 95% confidence interval were reported when available from each systematic review. The quality of systematic reviews was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) tool. A narrative synthesis was undertaken.

Results: Seventeen systematic reviews were identified, of which 1 was for RP, 5 for Sjögren's and 11 for Scleroderma. There were some high-quality systematic reviews for Sjögren's and mortality of Scleroderma. However, there were only low-quality systematic reviews of prevalence and incidence of RP and Scleroderma. Furthermore, there were no systematic reviews for the mortality of RP. For RP, the pooled prevalence was 4850 per 100 000; pooled annual incidence was 250 per 100 000. For Sjögren's, prevalence was 60-70 per 100 000; annual incidence was 6.92 per 100 000 and the pooled standardized mortality ratio ranged from 1.38 to 1.48. For Scleroderma, pooled prevalence ranged from 17.6 to 23 per 100 000; annual incidence was 1.4 per 100 000; and the pooled standardized mortality ratio ranged from 2.72 to 3.53.

Conclusion: The outcomes of RP were less well described compared with Sjögren's and Scleroderma. There was a lack of high-quality systematic reviews for the prevalence and incidence of RP and Scleroderma. Therefore, further studies and systematic reviews with rigorous case definitions, assessing different ethnic groups are warranted in this area.

Keywords: Raynaud’s; Sjögren’s; and scleroderma; incidence; mortality; prevalence; umbrella review.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA diagram of identification and screening of RP studies
Figure 2.
Figure 2.
PRISMA diagram of identification and screening of SS studies
Figure 3.
Figure 3.
PRISMA diagram of identification and screening of Scleroderma studies
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Garner R, Kumari R, Lanyon P, Doherty M, Zhang W.. Prevalence, risk factors and associations of primary Raynaud’s phenomenon: systematic review and meta-analysis of observational studies. BMJ Open 2015;5:e006389. - PMC - PubMed
    1. Bjork A, Mofors J, Wahren-Herlenius M.. Environmental factors in the pathogenesis of primary Sjogren’s syndrome. J Intern Med 2020;287:475–92. - PubMed
    1. Ramos PS. Epigenetics of scleroderma: integrating genetic, ethnic, age, and environmental effects. J Scleroderma Relat Disord 2019;4:238–50. - PMC - PubMed
    1. Singh AG, Singh S, Matteson EL.. Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2016;55:450–60. - PMC - PubMed
    1. Huang H, Xie W, Geng Y, Fan Y, Zhang Z.. Mortality in patients with primary Sjogren’s syndrome: a systematic review and meta-analysis. Rheumatology (Bulgaria) 2021;60:4029–38. - PubMed

LinkOut - more resources